ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
2,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,Y
3,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
4,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
5,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
6,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
7,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
8,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
8,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
8,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
9,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
10,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
11,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
13,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
14,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
15,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
15,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
16,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
17,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
18,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
18,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
19,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
19,2,Headache,Headaches NEC,Headaches,Nerv,N
20,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
21,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
22,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
23,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
24,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
25,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
26,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
27,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
28,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
29,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
29,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
30,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
32,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
33,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
33,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
34,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
35,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
36,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
37,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
38,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
39,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
40,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
41,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
42,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
42,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
43,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
43,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
43,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
44,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
45,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
46,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
49,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
51,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
52,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
52,2,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
53,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
53,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
53,3,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
53,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
54,1,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
54,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
55,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
56,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
57,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
58,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
58,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
59,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
60,1,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
61,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
62,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
62,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
62,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
62,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
62,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
62,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
63,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
63,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
64,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
65,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
65,2,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
65,3,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
65,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
